Haemonetics Corp. sell Bank of America Co.
Start price
07.02.25
/
50%
€57.00
Target price
07.02.26
€65.59
Performance (%)
-15.09%
End price
08.02.26
€48.40
Summary
This prediction ended on 08.02.26 with a price of €48.40. The price of Haemonetics Corp. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -15.09%. Bank_of_America_Co_ has a follow-up prediction for Haemonetics Corp., but this time predicts that Haemonetics Corp. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | 2.985% | 2.985% | - |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $68.00 price target on the stock, down previously from $95.00.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€55.50
22.05.26
22.05.26
€68.84
22.05.27
22.05.27
24.32%
20.07.26
20.07.26
